Patents
Patents for C07C 43 - Ethers; Compounds having groups, groups or groups (24,599)
02/2003
02/04/2003US6515183 Chiral diphenyldiphosphines and d-8 metal complexes thereof
02/04/2003US6515163 For use in nematic or cholesteric liquid-crystal mixtures which have positive dielectric anisotropy values; broad operating temperature range and low threshold voltage (for use in automobiles, portable devices-telephones, computers)
02/04/2003US6515117 C-aryl glucoside SGLT2 inhibitors and method
02/04/2003US6514898 Reacting solution of a rare earth salt in a C9-C30 active hydrogen containing organic compound with phosphoric acid to forma rare earth phosphate; preparing alkylene oxide adducts of organic compounds having active hydrogen atoms
02/04/2003US6514717 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
02/04/2003US6514632 Electroluminescent films and coatings for light emitting diodes; efficiency
02/04/2003CA2159038C Protecting group for use in oligodeoxyribonucleotide synthesis
01/2003
01/30/2003WO2003008363A1 Method of stabilizing reduced coenzyme q10 and method of acidic crystallization
01/30/2003WO2003008362A1 Novel 3-aryl-2-hydroxy propanol derivatives and a process for their preparation
01/30/2003WO2003008361A1 Process for the racemization of alcohols
01/30/2003WO2002006267A3 Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin a
01/30/2003CA2453135A1 Method of stabilizing reduced coenzyme q10 and method of acidic crystallization
01/28/2003US6512146 Process for preparing a dialkyl acetal of a C8 to C30 aldehyde
01/28/2003US6512083 Film prepared from the polymers of this invention. this invention is a light-emitting diode comprised of one or more layers of polymer films, at least one of which is derived from the oligomers and polymers of the invention.
01/23/2003WO2003006574A1 Liquid crystal compounds
01/23/2003WO2003006413A1 Process for production of fluorine-containing norbornene derivatives
01/23/2003WO2003006412A1 Method of producing reduced coenzyme q10
01/23/2003WO2003006411A1 Method of crystallizing reduced coenzyme q10 from aqueous solution
01/23/2003WO2003006410A1 Method of producing reduced coenzyme q10 as oily product
01/23/2003WO2003006409A1 Method of producing reduced coenzyme q10 crystals with excellent handling properties
01/23/2003WO2003006408A1 Method of producing reduced coenzyme q10 using solvent with high oxidation-protective effect
01/23/2003WO2003006151A1 Microencapsulated catalyst, methods of preparation and methods of use thereof
01/23/2003WO2002010106A1 Processes for the preparation of fluorinated acyl fluorides and fluorinated vinyl ethers
01/23/2003WO2001098245A3 Triphenyl compounds as interleukin-4 antagonists
01/23/2003US20030018207 Pharmaceutical medication associated with insulin resistance; patient with prophylaxis conditions having reduced sensitivity to insulin
01/23/2003US20030018192 Preparation of substituted aromatic compounds
01/23/2003US20030018013 Cardiovascular disorders; antilipemic agents; Alzheimer's disease
01/23/2003CA2453165A1 Method of producing reduced coenzyme q10
01/23/2003CA2453164A1 Method of crystallizing reduced coenzyme q10 from aqueous solution
01/23/2003CA2453163A1 Method of producing reduced coenzyme q10 as oily product
01/23/2003CA2453113A1 Microencapsulated catalyst, methods of preparation and methods of use thereof
01/22/2003EP1277724A1 Method of preparing monofluoromethyl ethers
01/22/2003EP1276841A1 Alcohol alcoxylates used as low-foam, or foam-inhibiting surfactants
01/22/2003CN1099403C Novel ether compound and its preparing method
01/21/2003US6509509 Ester precursor is hydrolyzed in reaction mixture of solvent, metal hydride, and inert organic base
01/21/2003US6509507 Polymerizable biaryls, process for their preparation and their use
01/21/2003US6509309 Cleaning composition comprising alkoxy substituted perfluoro compounds
01/16/2003US20030013924 Perfluoropolyether primary bromides and iodides
01/16/2003US20030013923 Perfluoropolyether (pfpe) solvents and lubricants
01/16/2003US20030013922 Perfluoropolyether primary bromides and iodides
01/16/2003US20030013713 Compounds as PDE IV and TNF-inhibitors
01/15/2003EP1275678A2 Perfluoropolyethers (PFPEs) having at least an alkylether end group and respective preparation process
01/15/2003EP0929509B1 Liquid crystal alkenyl bicyclo 2.2.2]octanes and mixtures and devices containing such compounds
01/15/2003CN1391542A C13 alcohol mixture and functionalized C13 alcohol mixture
01/15/2003CN1390872A Polycarbonat with branching end group, polyester carbonate and polyester
01/15/2003CN1390821A Process for synthesizing benzyl-2-naphthylether
01/15/2003CN1390820A Process for preparing trifluomethoxybenzene
01/15/2003CN1390817A Process for synthesizing bipentaerythritol
01/15/2003CN1098844C Substituted biphenyloxazolines
01/15/2003CN1098833C Process for preparing orthoformate
01/14/2003US6506947 Fluorinated diol and method for the production thereof
01/14/2003US6506945 Process for preparing ether-capped poly(oxyalkylated) alcohol surfactants
01/14/2003US6506915 Stereospecific synthesis of optically pure trans (E)isomer of coenzyme Q10 starting from geranyl bromide and 2,3,4,5-tetramethoxytoluene
01/14/2003US6506800 For control of insect and acarid pests
01/14/2003US6506799 Treating or preventing a cardiovascular disease in a patient, comprising administering to a patient in need of such treatment or prevention a therapeutically effective amount of 6-(6-hydroxy-5,5-dimethylhexyloxy)-2,2-dimethyl-hexan-1-ol and
01/14/2003US6506701 Polymer-supported quenching reagent covalently reacts with unreacted starting materials
01/14/2003US6506459 Coating compositions containing alkoxy substituted perfluoro compounds
01/09/2003WO2003002500A1 Solvents containing cycloalkyl alkyl ethers and process for production of the ethers
01/09/2003US20030009061 Process for preparing an alkylcyclohexanol alkyleneoxide adduct
01/09/2003US20030009060 As starting materials for the production of liquid crystals, polymers and flame retardants
01/09/2003US20030009059 Process of preparing a fluid rare earth alkoxylation catalyst
01/09/2003US20030008775 Heat-sensitive recording material
01/08/2003EP1272471A1 Non-steroidal, tetracyclic compounds for estrogen-related treatments
01/08/2003EP1272444A1 Production of alkylated aromatic compounds using dealuminated catalysts
01/08/2003EP1220851A4 Carbon dioxide-philic compounds and methods of synthesis thereof
01/07/2003US6504063 Hydrogenation polyol in aqueous solution
01/07/2003CA2202349C Difluorooxymethane derivative and liquid crystal composition
01/07/2003CA2121250C The preparation, intermediates for the preparation and the use of a mixture of dodecadienol isomers
01/02/2003US20030004304 Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
01/02/2003EP1270535A2 Method to synthesise substituted aromatic compounds
01/02/2003EP1268382A2 Alkoxylated perfumed alcohols and the use thereof
01/02/2003EP1268381A1 Production of fluormethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
01/02/2003EP1268380A1 Method for producing alkenyl ethers
01/02/2003EP0912474B1 Process using cf2i2 and olefins for producing diiodo fluorocompounds, and products thereof
01/02/2003EP0821719B1 Liquid crystal compounds having a chiral fluorinated terminal portion
01/01/2003CN1388107A Liquid-liquid extraction process of dioxyethyl methane and water solution of ethanol
12/2002
12/31/2002USRE37947 Aromatic polyenic compounds and pharmaceutical/cosmetic compositions comprised thereof
12/31/2002US6500503 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
12/27/2002WO2002102858A1 Fluorine-containing compounds and polymers derived therefrom
12/27/2002CA2451426A1 Fluorine-containing compounds and polymers derived therefrom
12/26/2002US20020198412 (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate
12/26/2002US20020198188 A potent and safe inhibitors of mammalian cell proliferation for treating or preventing cancer, blood vessel proliferative disorders, fibrotic disorders and arteriosclerotic conditions
12/26/2002US20020198159 Use of stilbene derivatives substituted in position 3 as deodorant active agents in cosmetic compositions
12/26/2002US20020198107 Delivery systems for cyclopropenes
12/26/2002US20020197407 Reactive coalescents
12/24/2002US6498278 Alkoxylation of 6-membered alkylene carbonates
12/24/2002US6498256 Catalysts for asymmetric addition reactions, for example of hydrogen, to prochiral unsaturated organic compounds.
12/19/2002WO2002100904A1 Components and catalysts for the (co)polymerization of olefins
12/19/2002WO2002100803A2 Method for telomerizing non-cyclic olefins
12/19/2002WO2002042248A3 Naphthalene derivatives
12/19/2002US20020193641 Reaction of a phenol compound with a dialkyl carbonate; solvent-free at a pressure of .93 x 105-1.07 x 105 Pa, at a temperature of 100-200 degrees C., in the presence of an alkaline carbonates catalyst
12/19/2002US20020193619 Synthesized from o,m,or p-iodotoluene, rather than iodobenzene, therefore do not pose carcinogenic risk; one of aryl groups bonded to positive iodine ion contains methyl substituent, other contains hydroxyl-substituted alkoxy group
12/19/2002DE10128705A1 Polycarbonate, Polyestercarbonate und Polyester mit verzweigten Endgruppen Polycarbonates, polyester and polyester with branched end groups
12/18/2002EP1266924A2 Polycarbonates, polyestercarbonates and polyesters having branched endgroups
12/18/2002EP1265980A1 Use of aromatic alcohol alxoxylates in detergents and cosmetic formulations
12/18/2002EP0910328B1 Aqueous nacreous lustre concentrate
12/18/2002CN1096442C Process for preparation of pesticidal fluoroolefin compounds and intermediate compounds
12/17/2002US6495728 Aralkylation of a fluorobromoolefin with an aralkylzinc bromide or bis(aralkyl)zinc in presence of a palladium catalyst; preparation of the olefin from an aldehyde and cbr3f, a phosphine or phosphoramide and zinc
12/17/2002US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
12/17/2002US6495220 Disubstituted phenanthrenes and their use in liquid-crystal mixtures